Form 4 for CDLX Cardlytics, Inc.

Accepted 2022-11-03 00:00:00 ET · period of report 2022-10-06 · accession 0001666071-22-000138 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-11-03	2022-10-06	CDLX	Christiansen Andrew	CFO	M - OptEx	$0.00	+1,875	22.7K	+9%	$0
D	2022-11-03	2022-10-06	CDLX	Christiansen Andrew	CFO	M - OptEx	$0.00	-1,875	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-10-06	M	A	1,875	$0.00	22,715	D	—	—	(F1) Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
2	Derivative	Performance Stock Unit	2022-10-06	M	D	1,875	$0.00	0	D	— · — to —	1,875 Common Stock	(F2) Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "October Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the October Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 6 months after the October Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU vested 12 months after the October Certification.